ImmPACT Bio Announces California-Based GMP Facility for Clinical Production of IMPT-314, a CD19/CD20 CAR T Therapy for B-Cell Malignancies and Autoimmune Diseases
ImmPACT Bio Announces California-Based GMP Facility for Clinical Production of IMPT-314, a CD19/CD20 CAR T Therapy for B-Cell Malignancies and Autoimmune Diseases
Biomerics, the leading vertically integrated contract manufacturer for the interventional medical device market, announced today that it has entered into definitive agreements to merge with Precision Concepts’ medical business (“Precision Concepts Medical”).
Spartech, a leading manufacturer of engineered thermoplastics and custom packaging solutions, is pleased to announce that Royalite G50, a non-PVC rigid sheet product, meets stringent ASTM E84 Steiner Tunnel Test in accordance with their flame spread and smoke-developed indexes.
SaniSure, a global developer and manufacturer of single-use technology for the biopharmaceutical industry, announced today it has acquired GL Engineering (GLE) of East Hanover, New Jersey.
Cytiva’s FlexFactory is a one-stop solution for equipment and services following single-use technology and a modular design tailored to the manufacturer’s needs.
Smart Connected Robotics, BD Kiestra™ IdentifA system, is designed to automate the preparation of microbiology bacterial identification testing.
Sidus Space, Inc. is constructing a new, state of the art cleanroom to support the production, testing and integration of the LizzieSat™ satellite constellation.
AllCells, the industry leader in the procurement and customization of human-derived hematological tissues and services, is pleased to announce the expansion of its flagship processing facility in Alameda, California.
Amcor Unveils State-of-the-art Healthcare Packaging Facility In Singapore To Serve Accelerating Customer Demands In Asia Pacific
Sidco Filter Company recently acquired Roome Technologies a leading manufacturer of high-efficiency filters for the medical, cleanroom, aerospace and in-room air purifier industries.
Sartorius will expand its capacities for production, innovation, and storage at its French facilities in Aubagne, Cergy and Lourdes in order to meet the strong demand of the biopharmaceutical industry
The Global Pathogen Center for Pathogen Research and Human Health to broaden understanding of emerging pathogens – ranging from Zika virus to SARS-CoV-2 (which causes COVID-19) – and to expedite critically needed treatments and vaccines.